Back

Predicting the impact of non-pharmaceutical interventions against COVID-19 on Mycoplasma pneumoniae in the United States

Park, S. W.; Noble, B.; Howerton, E.; Nielsen, B. F.; Jiudice, S. S.; Ambroggio, L.; Dominguez, S.; Messacar, K.; Grenfell, B.

2024-08-20 infectious diseases
10.1101/2024.08.19.24312254 medRxiv
Show abstract

The introduction of non-pharmaceutical interventions (NPIs) against COVID-19 disrupted circulation of many respiratory pathogens and eventually caused large, delayed outbreaks, owing to the build up of the susceptible pool during the intervention period. In contrast to other common respiratory pathogens that re-emerged soon after the NPIs were lifted, longer delays (> 3 years) in the outbreaks of Mycoplasma pneumoniae (Mp), a bacterium commonly responsible for respiratory infections and pneumonia, have been reported in Europe and Asia. As Mp cases are continuing to increase in the US, predicting the size of an imminent outbreak is timely for public health agencies and decision makers. Here, we use simple mathematical models to provide robust predictions about a large upcoming Mp outbreak in the US. Our model further illustrates that NPIs and waning immunity are important factors in driving long delays in epidemic resurgence.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.